Previous close | 3.8700 |
Open | 3.9500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 3.8140 - 4.2700 |
52-week range | 2.5500 - 5.9700 |
Volume | |
Avg. volume | 5,491 |
Market cap | 6.579M |
Beta (5Y monthly) | 2.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Xenetic Biosciences ( NASDAQ:XBIO ) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up 49% from FY...
Key Insights Xenetic Biosciences will host its Annual General Meeting on 6th of December Total pay for CEO Jeff...
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 38.94% and 47.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?